Condition
Observational Study clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Observational Study clinical trials that are recruiting, at sites in 4 countries (most in China (2), United States (2), Taiwan (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest Observational Study clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Geniculate Artery Embolization for Knee Osteoarthritis in Cancer Patients | — | Houston, Texas | Recruiting | Sep 8, 2026 |
| Project VERANDA — a survey about barriers and privacy concerns to seeking help | — | Berlin, State of Berlin | Recruiting | Feb 20, 2026 |
| Bridging Cancer Care for Underserved Patients with Veris Health Platform | — | Columbus, Ohio | Recruiting | Feb 9, 2026 |
| Iruplinalkib for ALK-positive advanced lung adenocarcinoma after lorlatinib | — | Shenzhen, Guangdong | Recruiting | Jan 29, 2026 |
| A kidney cancer prediction model to guide treatment decisions, including for patients with tumor thrombus | — | Beijing, Beijing Municipality | Recruiting | Aug 12, 2025 |
| Understanding the progression of Sialidosis Type I | — | Taipei, Taipei | Recruiting | Mar 18, 2024 |
All recruiting trials (6)
-
Geniculate Artery Embolization for Knee Osteoarthritis in Cancer Patients
This study tests whether blocking knee blood vessels with a standard care procedure can help reduce pain and improve function in people with knee osteoarthritis who also have cancer.
-
Project VERANDA — a survey about barriers and privacy concerns to seeking help
An anonymous questionnaire for adults to see what barriers, privacy worries, and attitudes make people with sexual interest in children more or less likely to seek treatment.
-
Bridging Cancer Care for Underserved Patients with Veris Health Platform
This study tests a remote cancer care platform to see if it helps underserved adults with cancer stay connected to their care while receiving outpatient therapy.
-
Iruplinalkib for ALK-positive advanced lung adenocarcinoma after lorlatinib
We will try iruplinalkib in adults with advanced ALK-positive lung adenocarcinoma who progressed on or couldn't tolerate lorlatinib to see how well it works and how safe it is in routine care.
-
A kidney cancer prediction model to guide treatment decisions, including for patients with tumor thrombus
This project will test whether a new prediction model can guide treatment choices to improve survival for adults with renal cell carcinoma, including those with venous tumor thrombus.
-
Understanding the progression of Sialidosis Type I
This study is trying to understand how Sialidosis Type I affects people by checking their brain and eye health regularly to see how the condition changes over time.
Related topics
Quick answers
How many Observational Study clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), United States (2 trials), Taiwan (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.